Genomes of herpesvirus aotus type 2 (HVA-2) and bovine herpesvirus type 4 (BHV-4) have previously been shown to be closely similar. Moreover, preliminary serological data indicated that HVA-2 is antigenically related to BHV-4. To extend this study, structural components of four BHV-4 strains and HVA-2 were compared by SDS-PAGE, radioimmunoprecipitation and Western blotting. The overall pattern of structural proteins was the same for HVA-2 and BHV-4 but variations were observed in electrophoretic profiles of glycoproteins, mainly of the two major ones (gp6/gp 10/gp 17 and gp 11/VP24). Variations between HVA-2 and BHV-4 glycoproteins were greater than those observed among BHV-4 strains.
Three bovine herpesviruses (BHV) have been isolated from a variety of diseases and latent infections of cattle (Ludwig, 1983) . BHV-1 and BHV-2 are responsible for infectious bovine rhinotracheitis/pustular vulvovaginitis and bovine herpes mammillitis respectively. BHV-4 (Bartha et al., 1987) is readily distinguishable from other BHVs by serological comparisons with polyvalent or monovalent antibodies or by restriction enzyme analyses (reviewed by Thiry et al., 1989) . BHV-4 has been classified as a cytomegalovirus primarily because certain features of its replication cycle are characteristic of cytomegalovirus replication (Storz et al., 1984) . More recent observations on the structure of the genome of BHV-4 (Ehlers et al., 1985; Bublot et al., 1990) and the detection of a viral thymidine kinase (Kit et al., 1986) suggest however that BHV-4 may be a member of the gammaherpesvirinae group (Honess, 1984; Thiry et al., 1990; Staczek, 1990) .
BHV-4 has been isolated from diseased or healthy cattle (reviewed by Thiry et al., 1989; Staczek, 1990) . BHV-4 infection is distributed world-wide and its prevalence could be as high as 50~ depending on the country (Thiry et al., 1989) . Its pathogenic role remains unclear but its involvement in the aetiology of some diseases of the genital tract has been suggested (reviewed by Thiry et al., 1989 Thiry et al., , 1990 . BHV-4 has also been isolated from sheep (Van Opdenbosch et al., 1986) , American bison (Bison bison) (Todd & Storz, 1983) , African buffalo (Syncerus caffer) (Rossiter et al., 1989) and cats (Fabricant & Gillespie, 1974; Kit et al., 1986; Kruger et al., 1989) . Recently, it was shown also that herpesvirus aotus 0001-0027 © 1991 SGM type 2 (HVA-2), isolated from an uninoculated kidney cell culture obtained from an apparently normal owl monkey (Aotus trivirgatus) (Barahona et al., 1973) , has genomic identity with BHV-4 (Bublot et al., 1991b) . Moreover, preliminary studies by indirect immunofluorescence showed a total serological cross-reaction between BHV-4 and HVA-2. These results suggest that HVA-2 is either a BHV-4 contaminant of an owl monkey kidney (OMK) cell culture or an isolate from an owl monkey accidentally infected with BHV-4 (Bublot et al., 1991 b) . This latter hypothesis could explain the presence of specific antibodies in the sera of owl monkeys. Indeed, preliminary serological data showed 42 ~ (44/106) of owl monkeys seropositive for HVA-2 in two primate research centres (Barahona et al., 1973) .
Twenty-nine BHV-4 structural proteins have been identified previously by SDS-PAGE of purified labelled virus, 10 of them being glycosylated. Three major glycoproteins were identified by anti-BHV-4 monoclonal antibodies (MAbs) (Dubuisson et al., 1989b; J. Dubuisson et al., unpublished results) . The first one is a complex of three glycopolypeptides (gp6/gpl0/gpl7) in which gpl0 and gpl7 are linked by disulphide bonds and gp6 is non-covalently linked to the others. The second is made up of one glycopolypeptide (gpl 1) non-covalently linked to a non-glycosylated polypeptide (VP24). The third is a single glycopolypeptide (gp8). A precursor has been identified for gpl0 and gpl7 in the first glycoprotein [p(gpl0/gpl7)] (Dubuisson et al., 1989b) .
To prove the antigenic relationship between BHV-4 and HVA-2, structural proteins of the two viruses were compared. This work focused mainly on glycoproteins which are more exposed to the selective pressure of the immune response. As the structural proteins of only one BHV-4 strain (V.Test) have already been identified (Dubuisson et al., 1989b) , three other BHV-4 strains were introduced in this work in order to determine whether variation between BHV-4 and HVA-2 structural components is at a similar level to that between BHV-4 strains.
The BHV-4 strains used in this work were the V.Test strain isolated from a case of orchitis (Thiry et al., 1981) , the European reference strain Movar 33/63 (ATCCVR-842) isolated from a cow showing keratoconjunctivitis (Bartha et al., 1966) , the American reference strain DN 599 (ATCCVR-631) isolated from a calf with respiratory disease (Mohanty et al., 1971 ) and the K10/82 strain isolated from lung foetal cell culture (Metzler & Wyler, 1986) kindly provided by A. Metzler (University of Zfirich, Switzerland). The HVA-2 isolate OMKI 68-69 was isolated from a kidney cell culture obtained from an apparently healthy owl monkey (Barahona et al., 1973) and was kindly provided by M. D. Daniel (Regional Primate Research Centre, Harvard Medical School, Southborough, Mass., U.S.A.). Madin Darby bovine kidney (MDBK) cells were cultured in MEM as previously described (Dubuisson et al., 1987) for BHV-4 and HVA-2 multiplication. Each virus except for K 10/82 was plaque-purified three times.
For the preparation of purified labelled virus, MDBK cells grown to confluence were infected at a multiplicity of 10 p.f.u./cell and incubated for 2 h at 37 °C in MEM with 2~ newborn calf serum. After that, MEM was replaced by methionine-free medium (Gibco). Eight hours after infection, 10 ~tCi/ml of [35S]methionine (> 800 Ci/mmol; Amersham) was added in methioninefree medium. Three days later, when c.p.e, involved less than 30~ of the cell sheet, the virus was harvested and purified from supernatant fluid by differential centrifugation through a cushion of 30~o sucrose in phosphatebuffered saline [(PBS : 3 mM-KCI, 1.5 mM-KH2PO4, 0-14 M-NaC1, 6-5 mM-Na2HPO4(2H20), pH 7.2] and the pellet was centrifuged through a potassium tartrate gradient (20 to 50~ potassium tartrate in PBS, pH 7.2) as described by Misra et al. (1981) . The virion envelope was removed as described by Hampl et al. (1984) . Labelled proteins were separated by SDS-PAGE (Laemmli, 1970) . After electrophoresis, gels were treated with sodium salicylate (Chamberlain, 1979) , dried and exposed to Kodak XAR-5 films. The Mr values of radioactive bands were determined by running, in parallel, l~C-labelled Mr standards (Amersham).
MAbs to BHV-4 have been characterized previously (Dubuisson et al., 1989a (Dubuisson et al., , b, 1990 . These MAbs were directed against gp6/gpl0/gpl7 and gpl 1/VP24, and a third glycoprotein was recently identified as gp8 (J. Dubuisson et al., unpublished results) . Antisera to BHV-4 strain V.Test were produced in infected rabbits as described by Osorio et al. (1982) and collected at day 41 after inoculation or in rabbits classically immunized by three injections of semi-purified virus in Freund's adjuvant at 15-day intervals (Dubuisson et al., 1988) . Antiserum to HVA-2 was produced in an infected rabbit and collected at day 41 after inoculation.
Antigen used for immunoprecipitation was prepared as described by van Drunen Littel-van den Hurk et al. (1984) and the immunoprecipitation procedure was as previously described (Dubuisson et al., 1989a) . In some experiments, immunoprecipitated proteins bound to Protein A-Sepharose (Pharmacia) in the appropriate buffer ( 50 mM-potassium phosphate buffer pH 7.4, 20 mM-EDTA, 0-5~ Triton X-100, 0.4 mM-PMSF) were released by boiling and were digested with 0.5 units of endoglycosidase F/N-glycosidase F (Boehringer Mannheim) at 37 °C overnight. After incubation, an equal volume of 2 x Laemmli sample buffer was added to the reaction, and the samples were boiled for 2 min prior to SDS-PAGE. Control samples without enzyme were treated identically.
For Western blotting, BHV-4-and HVA-2-infected MDBK cells (m.o.i. > 1) were harvested at 48 h postinoculation. Cells were lysed with radioimmunoprecipitation assay (RIPA) buffer (0-15 M-NaC1, 0.05 M-Tris-HC1 pH 7.2, 1~o Triton X-100, 0"1~o SDS, 1~ sodium deoxycholate, 0-1 ~ NAN3) and centrifuged for 15 min in an Eppendorf centrifuge. The supernatant was stored at -80 °C and used as an antigen for Western blotting analysis. Western blotting was performed according to Herring & Sharp (1984) . Fig. 1 compares the electrophoretic profiles of gp6/gpl0/gpl7 for BHV-4 strains and HVA-2. Variations were observed for gp6 and gpl0: 145K (gp6) and 124K (gpl0) for V.Test and Movar 33/63; 150K and 126K for DN 599 and K 10/82; 160K and 131K for HVA-2. Moreover a 60K band was also detected for HVA-2. A 190K band detected in some RIPAs corresponded to incompletely reduced gpl0/gpl7. Lane 4 shows bands of a weaker intensity. Western blotting using the same antigp6/gpl0/gpl7 MAb permitted identification of the precursor to gpl0/gpl7 [p(gpl0/gpl7)] of Mr 132K for V.Test and Movar 33/63, and 140K for DN 599, K10/82 and HVA-2 (data not shown). The 60K protein identified in HVA-2 was also identified by Western blotting.
The glycoprotein gpll showed the same Mr for the four BHV-4 strains (lI5K) but a lower Mr for HVA-2 (109K). Lane 4 showed a band of a weaker intensity. A 54K protein of weak intensity was also detected in RIPA using some viral preparations (Fig. 2) (Fig. 3) . The glycoprotein gp8 did not show any Mr variation between BHV-4 strains and HVA-2 (data not shown). When [3H]glucosamine-labelled infected cell lysate was used as the antigen, antisera to BHV-4 or to HVA-2 showed the same Mr variations as those observed using MAbs to individual glycoproteins (Fig 4) .
The endoglycosidase F/N-glycosidase F digestion of the glycoproteins gp6/gp I 0/gp 17 and gp 11/VP24 showed a reduction in the Mr of their individual components (data not shown). Indeed, the glycoprotein gp6/p(gpl0/gpl7)/gpl0/gpl7
showed an Mr of 120K/100K/80K/48K instead of 145K/132K/124K/52K for the V. Hyperimmune serum raised against V.Test structural proteins precipitated most of the structural proteins identified in the V.Test strain and a new band of 21-5K was detected for Movar 33/63 and another of 27K for HVA-2 (data not shown). Electrophoretic profiles of purified labelled BHV-4 strains and HVA-2 showed the same protein patterns except for their major glycoproteins and a new band of 34K observed in all the viruses but V.Test (data not shown).
BHV-4 and HVA-2 exhibit the same genomic structure and closely conserved restriction maps suggesting that HVA-2 could belong to the BHV-4 group (Bublot et al., 1991 b) . Moreover comparison of HVA-2 and BHV-4 structural proteins revealed similar electrophoretic profiles, although Mr variations observed among BHV-4 strains were less than those observed between BHV-4 and HVA-2.
Variations were observed mainly in the electrophoretic profiles of the two major glycoproteins gp6/gp 10/gp 17 and gpl I/VP24. Among the subunits of the former, gpl7 did not show any variation of Mr in BHV-4 strains and HVA-2 but an additional band of 60K was observed for HVA-2. This protein was present in purified virus and was detected by RIPA and Western blotting using antigpl7 MAbs suggesting that this 60K protein shares common epitopes with gpl7 and p(gpl0/gpl7). The detection of an additional band of 60K could be due to the presence of two viral populations in HVA-2 which is however unlikely since the virus has been cloned three times previously. Glycoprotein gpl 1 showed Mr variation in HVA-2 only and the coprecipitated VP24 polypeptide showed a slight variation of Mr in K10/82 and HVA-2. In some viral preparations, a 54K protein was coprecipitated with gpl 1 but this band was faint and diffuse suggesting that it could be a degraded product. Another polypeptide of Mr 103K was also coprecipitated with gpll by RIPA using [3SS]methionine-labelled infected cell lysate as antigen but this band was not detected in purified virus, suggesting that this protein is probably a precursor of gpl 1 (pgpl 1).
The estimated Mr for polypeptides of the reference V.Test strain used in our laboratory showed some variations when compared to previous results (Dubuisson et al., 1989b) . Indeed glycoproteins gp6/gpl0/gpl7 and gpl 1/VP24 showed an Mr of 145K/124K/52K and 115K/16" 5K respectively instead of 150K/120K/51K and 120K/16-5K. These variations could be due to differences in post-translational modifications since MDBK cells were used in this work instead of the GBK (Georgia bovine kidney) cells previously used. Moreover glycoproteins gpl0 and gpl I previously shown to have the same M r (120K), had Mr values of 124K and 115K respectively. These results confirm that gpl0 and gpll are two distinct polypeptides.
The Mr variations of gp6, gpl0 and p(gpl0/gpl7) observed among BHV-4 strains tested in this work showed that the V.Test strain has the same glycoprotein profile as Movar 33/63, and the K10/82 strain the same profile as DN 599. These preliminary results suggest that the comparison of glycoproteins among BHV-4 strains allows differentiation into two groups, 'Movar-like' and 'DN-like', as shown at the genomic level (Bublot et al., 1991a) . Indeed, the V.Test strain was classified as 'Movar-like' and K10/82 as 'DN-like' (Bublot et al., , 1991a . Nevertheless the study of glycoprotein variations among BHV-4 strains has to be extended to a larger number of strains before establishing a correlation between genomic and antigenic variations. HVA-2 which was classified as 'Movar-like' in the classification of Bublot et al. (1991 b) showed a glycoprotein pattern distinct from the Movar 33/63 and DN 599 strains.
Endoglycosidase F/N-glycosidase F reduced the Mr of gp6/p(gp 10/gp 17)/gp 10/gp 17 and of gp 11/pgpl 1. On the basis of these results, N-linked oligosaccharides contribute about 25K to the Mr of gp6, 32K to the Mr of p(gpl0/gpl7), 44K to gpl0 and only 4K to gpl7 of the BHV-4 strain V.Test. When compared to V.Test, the Mr of deglycosylated gp6/p(gp 10/gp 17)/gp 10/gp 17 of DN 599 showed almost the same differences as those observed for the non-deglycosylated forms suggesting that the variations ofglycoprotein Mr values obtained for the BHV-4 strains V.Test and DN 599 are not necessarily due to the addition of N-linked glycans. Nevertheless, HVA-2 showed a greater decrease in the Mr of deglycosylated gp6 and p(gpl0/gpl7) than those of the BHV-4 strain V.Test showing that N-linked oligosaccharides contribute about 38K (instead of 25K for V.Test) to the Mr ofgp6 and 47K (instead of 32K for the V.Test) to the Mr of p(gpl0/gpl7). Moreover the additional band of 60K detected in HVA-2 showed an Mr of 28K after deglycosylation suggesting that this protein is also highly glycosylated. Altogether these results suggest that a major part of the Mr variations of the HVA-2 glycoprotein gp6/p(gpl0/gpl7)/gpl0/gpl7 is due to the presence of N-linked glycans. Endoglycosidase F/N-glycosidase F digestion of gpl 1/pgpl 1 showed that these two polypeptides are also rich in N-linked oligosaccharides but the Mr variations of HVA-2 gpl 1/pgpl 1 glycoproteins do not appear to be due to the presence of N-linked glycans.
Genomic analysis of BHV-4 and HVA-2 suggests that HVA-2 is a BHV-4 strain because the range of variations in DNA profiles is the same between BHV-4 reference strains and HVA-2 as that among conventional BHV-4 strains (Bublot et al., 1991 b) . The antigenic comparison between BHV-4 and HVA-2 showed also that these viruses are similar but Mr variations observed for HVA-2 glycoproteins were greater than among BHV-4 strains. In vivo and in vitro host ranges of BHV-4 are relatively wide . Therefore, infection by a contaminated biological preparation or an accidental infection of owl monkeys in a research centre by a BHV-4-infected animal of another species cannot be excluded (Bublot et al., 1991b) . It could be suggested that, if BHV-4 has accidentally infected owl monkeys, viral glycoproteins have evolved in the latter species for better adaptation. Modifications of viral glycoproteins could explain the new cell tropism. Similarly, it has been suggested that an accidental transmission of BHV-4 to cats could account for the genomic and antigenic similarities between the feline cell-associated herpesvirus (FeCAHV or FHV-2) and BHV-4 (Kit et al., 1986; Thiry et al., 1990) . For this virus, glycoproteins were not identified, but a preliminary experiment where cats were inoculated intravenously with the BHV-4 Movar 33/63 strain, did not produce any sign of virus multiplication suggesting that BHV-4 may require modification to infect the cat successfully (Thiry et al., 1991) . Cross infections thus need to be performed to confirm whether or not BHV-4 is able to undergo an adaptation in new hosts (owl monkey, cat, etc.). Moreover, in the light of these results, it could be interesting to test the susceptibility of other species to BHV-4.
